Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07430085 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Post-Operative Pain Relief: Zynrelef or Periarticular Injections in RATKA

StatusNot Yet Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Jan 31, 2026 to Jul 31, 2026v3
  2. Interventions: bupivacaine + ketorolac + lidocaine (Combination Product), bupivacaine-meloxicam (extended release) (Combination Product) to Bupivacaine (Drug), Ketorolac (Drug), Lidocaine (drug) (Drug), bupivacaine-meloxicam (extended release) (Combination Product)
    • Secondary endpoints revised (2)
    • Study description expanded, about 5 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Prospective Cohort of patients who are scheduled for a Robot Assisted Total Knee Arthroplasty (RATKA). A prospective survey of patient reported outcome measures (Numeric Rating Scale) will be obtained postoperatively of 72 hours, as well as at the postoperative opioid consumption after 72 hours.
Trial Details
NCT Number NCT07430085
Lead Sponsor Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Conditions
(from sponsor)		 Periarticular Block, Osteoarthritis (OA), Osteoarthritis (OA) of the Knee, Pain After Surgery, Knee Arthroplasty, Total
Related terms Osteoarthritis
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov